Literature DB >> 24719044

Fatigue in adults with Marfan syndrome, occurrence and associations to pain and other factors.

Trine Bathen1, Gry Velvin, Svend Rand-Hendriksen, Hilde Stendal Robinson.   

Abstract

This study aims to investigate how fatigue affects adults with verified Marfan syndrome (MFS) in their daily lives, by examining fatigue levels and prevalence of severe fatigue compared to the general Norwegian population and individuals with other comparable chronic conditions. We investigated associations between socio-demographic characteristics, Marfan-related health problems, pain and fatigue. A cross-sectional study was conducted, using a postal questionnaire including the Fatigue Severity Scale (FSS) and questions on socio-demographic characteristics, Marfan-related health problems and pain. One hundred seventeen persons with MFS were invited to participate, 73 answered (62%). Participants reported significantly higher FSS scores and prevalence of severe fatigue compared to the general Norwegian population and patients with rheumatoid arthritis (RA), but lower than for other chronic conditions. Participants with chronic pain reported higher fatigue scores than those without chronic pain. Participants on disability benefits reported higher fatigue scores than participants who were working or enrolled in higher education. Marfan-related health problems like aortic dissection and use of blood pressure medication were not significantly associated with fatigue. In multivariable regression analyses chronic pain and employment status were significantly associated with fatigue. The final multivariable model explained 24% of the variance in fatigue scores. Our results show that fatigue is common in MFS patients and that it interferes with their daily lives. Chronic pain and employment status show significant associations to fatigue. This implies that fatigue is important to address when meeting MFS patients in clinical practice. There is need for more research on fatigue in Marfan syndrome.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  chronic pain; employment; fatigue; fatigue severity scale; marfan syndrome

Mesh:

Year:  2014        PMID: 24719044     DOI: 10.1002/ajmg.a.36574

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  20 in total

1.  Satisfaction with life in adults with Marfan syndrome (MFS): associations with health-related consequences of MFS, pain, fatigue, and demographic factors.

Authors:  Gry Velvin; Trine Bathen; Svend Rand-Hendriksen; Amy Østertun Geirdal
Journal:  Qual Life Res       Date:  2016-01-04       Impact factor: 4.147

2.  Marfan Syndrome and Quality of Life in the GenTAC Registry.

Authors:  Judith Z Goldfinger; Liliana R Preiss; Richard B Devereux; Mary J Roman; Tabitha P Hendershot; Barbara L Kroner; Kim A Eagle
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

Review 3.  A Review of Psychosocial Factors of Marfan Syndrome: Adolescents, Adults, Families, and Providers.

Authors:  Cory Nielsen; Ileana Ratiu; Mitra Esfandiarei; Angela Chen; Elif Seda Selamet Tierney
Journal:  J Pediatr Genet       Date:  2019-07-25

4.  Characterization of pain, disability, and psychological burden in Marfan syndrome.

Authors:  Traci J Speed; Vani A Mathur; Matthew Hand; Bryt Christensen; Paul D Sponseller; Kayode A Williams; Claudia M Campbell
Journal:  Am J Med Genet A       Date:  2016-11-14       Impact factor: 2.802

5.  Health-Related Quality of Life in Children and Young Adults with Marfan Syndrome.

Authors:  Jill C Handisides; Danielle Hollenbeck-Pringle; Karen Uzark; Felicia L Trachtenberg; Victoria L Pemberton; Teresa W Atz; Timothy J Bradley; Elizabeth Cappella; Sylvia De Nobele; Georgeann Keh-Teng Groh; Michelle S Hamstra; Rosalind Korsin; Jami C Levine; Bergen Lindauer; Aimee Liou; Meghan K Mac Neal; Larry W Markham; Tonia Morrison; Kathleen A Mussatto; Aaron K Olson; Mary Ella M Pierpont; Reed E Pyeritz; Elizabeth A Radojewski; Mary J Roman; Mingfen Xu; Ronald V Lacro
Journal:  J Pediatr       Date:  2018-09-27       Impact factor: 4.406

6.  Quality of life in patients with Marfan syndrome: a cross-sectional study of 102 adult patients.

Authors:  Caroline Andonian; Sebastian Freilinger; Stefan Achenbach; Peter Ewert; Ulrike Gundlach; Harald Kaemmerer; Nicole Nagdyman; Rhoia Clara Neidenbach; Lars Pieper; Jörg Schelling; Michael Weyand; Jürgen Beckmann
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 7.  Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson
Journal:  Appl Clin Genet       Date:  2015-06-16

8.  Structural equation modeling of the quality of life for patients with marfan syndrome.

Authors:  Ju Ryoung Moon; Yong Ae Cho; June Huh; I-Seok Kang; Duk-Kyung Kim
Journal:  Health Qual Life Outcomes       Date:  2016-06-02       Impact factor: 3.186

Review 9.  The role of the multidisciplinary health care team in the management of patients with Marfan syndrome.

Authors:  Yskert von Kodolitsch; Meike Rybczynski; Marina Vogler; Thomas S Mir; Helke Schüler; Kerstin Kutsche; Georg Rosenberger; Christian Detter; Alexander M Bernhardt; Axel Larena-Avellaneda; Tilo Kölbel; E Sebastian Debus; Malte Schroeder; Stephan J Linke; Bettina Fuisting; Barbara Napp; Anna Lena Kammal; Klaus Püschel; Peter Bannas; Boris A Hoffmann; Nele Gessler; Eva Vahle-Hinz; Bärbel Kahl-Nieke; Götz Thomalla; Christina Weiler-Normann; Gunda Ohm; Stefan Neumann; Dieter Benninghoven; Stefan Blankenberg; Reed E Pyeritz
Journal:  J Multidiscip Healthc       Date:  2016-11-03

10.  Chronic pain and fatigue in adults with congenital unilateral upper limb deficiency in Norway. A cross-sectional study.

Authors:  Heidi Johansen; Trine Bathen; Liv Øinæs Andersen; Svend Rand-Hendriksen; Kristin Østlie
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.